Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Mechanism of action of mitoxantrone.
GlaxoSmithKline Product Development Pipeline
The effect of dimethyl fumarate (Tecfidera™) on lymphocyte counts: A potential contributor to progressive multifocal leukoencephalopathy risk.
A phase 3 trial of extended release oral dalfampridine in multiple sclerosis.
Correlation between anti-interferon-β binding and neutralizing antibodies in interferon-β-treated multiple sclerosis patients.
Copolymer 1 reduces relapse rate and improves disability in relapsing-remitting multiple sclerosis: results of a phase III multicenter, double-blind placebo-controlled trial. The Copolymer 1 Multiple Sclerosis Study Group.
High consumption of coffee is associated with decreased multiple sclerosis risk; results from two independent studies.
Immunosuppressive therapy reduces axonal damage in progressive multiple sclerosis.
Primary results of DECIDE: a randomized, double-blind, double-dummy, active-controlled trial of daclizumab HYP vs. Interferon β-1a in RRMS patients
17 beta-estradiol inhibits cytokine, chemokine, and chemokine receptor mRNA expression in the central nervous system of female mice with experimental autoimmune encephalomyelitis.
Masitinib in the treatment of active rheumatoid arthritis: results of a multicentre, open-label, dose-ranging, phase 2a study.
Meta-analysis of genome scans and replication identify CD6, IRF8 and TNFRSF1A as new multiple sclerosis susceptibility loci.
[Pharmacoeconomic analysis of the efficacy of natalizumab in relapsing-remitting multiple sclerosis].
The differential diagnosis of neurological diseases by fractionating electrophoretically the CSF gamma-globulins.
Antibody to α4 integrin suppresses natural killer cells infiltration in central nervous system in experimental autoimmune encephalomyelitis.
Dimethyl fumarate attenuates experimental autoimmune neuritis through the nuclear factor erythroid-derived 2-related factor 2/hemoxygenase-1 pathway by altering the balance of M1/M2 macrophages.
Headaches in multiple sclerosis: Cross-sectional study of a multiethnic population.
Efficacy and safety of oral fumarate in patients with relapsing-remitting multiple sclerosis: a multicentre, randomised, double-blind, placebo-controlled phase IIb study.
The employment concerns of Americans with multiple sclerosis: Perspectives from a national sample.
Oxidative stress is differentially present in multiple sclerosis courses, early evident, and unrelated to treatment.
Myelin Oligodendrocyte Glycoprotein-Associated Pediatric Central Nervous System Demyelination: Clinical Course, Neuroimaging Findings, and Response to Therapy.
Firategrast
Microglia in health and disease.
Serum IL-33 levels and skin mRNA expression in Behçet's disease.
Cerebrospinal fluid markers reveal intrathecal inflammation in progressive multiple sclerosis.

Pages